7 results
Clostridium Dificile Risk by Antibiotic Class

Pooled and study-specific risk estimates of community-associated CDI risk by antibiotic
Risk by Antibiotic ... community-associated CDI risk by antibiotic ... CDifficile #Infection #Antibiotics ... #Association #Pharmacology ... #Table #Comparison
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... Staphylococcus aureus • Clostridium ... fasciitis #Skin #IDSA ... Treatment #management #antibiotics ... #pharmacology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... of the Primary Clostridium ... infection Episode #Pharmacology ... IDSA2017 #Adjunct #Antibiotics
Antibiogram - Antibiotic Resistance Table for Severe Multidrug Resistant Bacteria

ESBL Enterobacteriaceae
Carbapenem-Resistant Enterobacteriaceae
MDR Pseudomonas Aeruginosa
Carbapenem-Resistant Acinetobacter

Adapted from
Antibiogram - Antibiotic ... Ryan Shields via Antibiotic ... #Antibiogram #Antibiotic ... InfectiousDiseases #Resistant #Comparison ... #Table #Pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... if MIC<0.12 ug/ml ... Therapy for Treating Clostridium ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... chew, or crush tablet ... suspension 4–6 mL ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommended Dosages of Antimicrobial Agents Administered by the Intraventricular Route
Amikacin - 5–50 mg
Amphotericin B -
IDSA Recommended ... Intraventricular #antibiotics ... #dosing #pharmacology ... ventriculitis #table ... #idsa